Cargando…
AMPK activator decelerates osteoarthritis development by inhibition of β-catenin signaling in chondrocytes
BACKGROUND: Osteoarthritis (OA) is a common degenerative joint disease with significant negative impact on the quality of life. It has been reported that abnormal upregulation of β-catenin signaling could lead to OA development; however, the upstream regulatory mechanisms of β-catenin signaling have...
Autores principales: | Zhu, Zhenglin, Huang, Yanran, Li, Jun, Yi, Dan, Liao, Junyi, Xiao, Jun, Xiao, Guozhi, Tong, Liping, Huang, Wei, Di, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Speaking Orthopaedic Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668625/ https://www.ncbi.nlm.nih.gov/pubmed/36439631 http://dx.doi.org/10.1016/j.jot.2022.10.005 |
Ejemplares similares
-
Deletion of Runx2 in Articular Chondrocytes Decelerates the Progression of DMM-Induced Osteoarthritis in Adult Mice
por: Liao, Lifan, et al.
Publicado: (2017) -
Activation of β‐catenin in Col2‐expressing chondrocytes leads to osteoarthritis‐like defects in hip joint
por: Xia, Chenjie, et al.
Publicado: (2019) -
Wnt/β-catenin signaling may induce senescence of chondrocytes in osteoarthritis
por: Li, Weijun, et al.
Publicado: (2020) -
Metformin limits osteoarthritis development and progression through activation of AMPK signalling
por: Li, Jun, et al.
Publicado: (2020) -
Chondrocyte-Specific Inhibition of β-Catenin Signaling Leads to Dysplasia of the Caudal Vertebrae in Mice
por: Shu, Bing, et al.
Publicado: (2013)